E
Ocugen, Inc.
OCGN
$0.689
$0.04186.46%
E
Sell
3/4/2024Downgrade
Ocugen, Inc. (OCGN) was downgraded to E+ from D- on 3/4/2024 due to a decline in the valuation index.
Ocugen, Inc. (OCGN) was downgraded to E+ from D- on 3/4/2024 due to a decline in the valuation index.
D
Sell
2/16/2024Upgraded
Ocugen, Inc. (OCGN) was upgraded to D- from E+ on 2/16/2024 due to an increase in the volatility index.
Ocugen, Inc. (OCGN) was upgraded to D- from E+ on 2/16/2024 due to an increase in the volatility index.
E
Sell
12/14/2023Downgrade
Ocugen, Inc. (OCGN) was downgraded to E+ from D- on 12/14/2023 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.05 to 0.06, and the quick ratio declined from 5.24 to 4.8.
Ocugen, Inc. (OCGN) was downgraded to E+ from D- on 12/14/2023 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.05 to 0.06, and the quick ratio declined from 5.24 to 4.8.
D
Sell
3/14/2023Downgrade
Ocugen, Inc. (OCGN) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
Ocugen, Inc. (OCGN) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/23/2023Upgraded
Ocugen, Inc. (OCGN) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index and valuation index.
Ocugen, Inc. (OCGN) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index and valuation index.
D
Sell
2/8/2023Downgrade
Ocugen, Inc. (OCGN) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index, total return index and solvency index. Debt to equity increased from 0.02 to 0.03, the quick ratio declined from 11.12 to 6.82, and EBIT declined 18.17% from -$19.57M to -$23.12M.
Ocugen, Inc. (OCGN) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index, total return index and solvency index. Debt to equity increased from 0.02 to 0.03, the quick ratio declined from 11.12 to 6.82, and EBIT declined 18.17% from -$19.57M to -$23.12M.
D
Sell
5/31/2022Upgraded
Ocugen, Inc. (OCGN) was upgraded to D from D- on 05/31/2022.
Ocugen, Inc. (OCGN) was upgraded to D from D- on 05/31/2022.
D
Sell
5/13/2022Downgrade
Ocugen, Inc. (OCGN) was downgraded to D- from D on 5/13/2022 due to a decline in the total return index.
Ocugen, Inc. (OCGN) was downgraded to D- from D on 5/13/2022 due to a decline in the total return index.
D
Sell
5/4/2022Upgraded
Ocugen, Inc. (OCGN) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index.
Ocugen, Inc. (OCGN) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index.
E
Sell
5/1/2022Downgrade
Ocugen, Inc. (OCGN) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
Ocugen, Inc. (OCGN) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
Ocugen, Inc. (OCGN) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index.
Ocugen, Inc. (OCGN) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index.
E
Sell
4/20/2022Downgrade
Ocugen, Inc. (OCGN) was downgraded to E+ from D on 4/20/2022 due to a significant decline in the total return index, solvency index and volatility index. The quick ratio declined from 17.23 to 13.57.
Ocugen, Inc. (OCGN) was downgraded to E+ from D on 4/20/2022 due to a significant decline in the total return index, solvency index and volatility index. The quick ratio declined from 17.23 to 13.57.
D
Sell
11/9/2021Upgraded
Ocugen, Inc. (OCGN) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
Ocugen, Inc. (OCGN) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
E
Sell
11/8/2021Downgrade
Ocugen, Inc. (OCGN) was downgraded to E+ from D on 11/8/2021 due to a substantial decline in the growth index and valuation index. Operating cash flow declined 312.66% from -$5.28M to -$21.8M, EBIT declined 262.9% from -$7.06M to -$25.61M, and earnings per share declined from -$0.038 to -$0.1327.
Ocugen, Inc. (OCGN) was downgraded to E+ from D on 11/8/2021 due to a substantial decline in the growth index and valuation index. Operating cash flow declined 312.66% from -$5.28M to -$21.8M, EBIT declined 262.9% from -$7.06M to -$25.61M, and earnings per share declined from -$0.038 to -$0.1327.
D
Sell
11/9/2020Upgraded
Ocugen, Inc. (OCGN) was upgraded to D from D- on 11/9/2020 due to a large increase in the growth index, solvency index and total return index. The quick ratio increased from 2.13 to 4.63, earnings per share increased from -$0.1934 to -$0.074, and debt to equity declined from 0.43 to 0.23.
Ocugen, Inc. (OCGN) was upgraded to D from D- on 11/9/2020 due to a large increase in the growth index, solvency index and total return index. The quick ratio increased from 2.13 to 4.63, earnings per share increased from -$0.1934 to -$0.074, and debt to equity declined from 0.43 to 0.23.
D
Sell
8/31/2020Upgraded
Ocugen, Inc. (OCGN) was upgraded to D- from E+ on 8/31/2020 due to an increase in the valuation index, growth index and total return index.
Ocugen, Inc. (OCGN) was upgraded to D- from E+ on 8/31/2020 due to an increase in the valuation index, growth index and total return index.
E
Sell
8/14/2020Downgrade
Ocugen, Inc. (OCGN) was downgraded to E+ from D- on 8/14/2020 due to a decline in the valuation index and growth index. Earnings per share declined from -$0.0749 to -$0.1934.
Ocugen, Inc. (OCGN) was downgraded to E+ from D- on 8/14/2020 due to a decline in the valuation index and growth index. Earnings per share declined from -$0.0749 to -$0.1934.
D
Sell
7/10/2020Upgraded
Ocugen, Inc. (OCGN) was upgraded to D- from E+ on 7/10/2020 due to an increase in the volatility index.
Ocugen, Inc. (OCGN) was upgraded to D- from E+ on 7/10/2020 due to an increase in the volatility index.
E
Sell
6/23/2020Downgrade
Ocugen, Inc. (OCGN) was downgraded to E+ from D- on 6/23/2020 due to a decline in the volatility index and total return index.
Ocugen, Inc. (OCGN) was downgraded to E+ from D- on 6/23/2020 due to a decline in the volatility index and total return index.
D
Sell
6/4/2020Upgraded
Ocugen, Inc. (OCGN) was upgraded to D- from E+ on 6/4/2020 due to an increase in the volatility index.
Ocugen, Inc. (OCGN) was upgraded to D- from E+ on 6/4/2020 due to an increase in the volatility index.
E
Sell
6/2/2020Upgraded
Ocugen, Inc. (OCGN) was upgraded to E+ from E on 6/2/2020 due to a large increase in the solvency index and volatility index.
Ocugen, Inc. (OCGN) was upgraded to E+ from E on 6/2/2020 due to a large increase in the solvency index and volatility index.
E
Sell
3/2/2020Upgraded
Ocugen, Inc. (OCGN) was upgraded to E from E- on 3/2/2020 due to an increase in the total return index.
Ocugen, Inc. (OCGN) was upgraded to E from E- on 3/2/2020 due to an increase in the total return index.
E
Sell
12/23/2019None
Ocugen, Inc. (OCGN) was downgraded to E- from U on 12/23/2019.
Ocugen, Inc. (OCGN) was downgraded to E- from U on 12/23/2019.
NASDAQ
04/02/2025 4:00PM Eastern
Quotes delayed
